期刊文献+

从经验医学、循证医学到精准医学的演变及评价 被引量:16

Analysis of the Clinical Medicine Development from Empirical Medicine,Evidence Based Medicine,to Precision Medicine
下载PDF
导出
摘要 现代医学经历了从经验医学到循证医学的发展,再演变到今天的精准医学,其螺旋式上升的发展途径符合辩证唯物主义否定之否定以及认识论的规律。经验医学看重临床实践经验,循证医学注重群体研究获得的证据,而精准医学则侧重于疾病的精准诊断和精准评估。本文将辩证唯物主义认识论与临床医学演变相联结,结合实例,详细地分析了各阶段医学观念演变的特点和局限性,用辩证唯物主义认识论的观点审视了现代医学从经验医学到循证医学再到精准医学的演变过程,并对精准医学的未来发展提出展望。 Modern medicine has experienced the development from empirical medicine, evidence-based medicine , andgradually to today’s precision medicine. The spiral development approach conforms to the diaknowledge and t he law ff t he nega t ion ff nega t i on. Empirical medicine values t he clinic prac tical expbased-medicine focuses on t he evidence which is acquired from cohor t s t udies. For precision meaccurate diagnosis and precise evaluation of disease. The present study analyzed the characteristics and limitations of different developing stages of medical conception in detail, combined with the dialectical materialist theory of knowledge and the development of clinical medicine. The dialectical materialist theory of knowledge process of the modern medicine development from empirical medicine, evidence-based medicine, to precision future development trend of precision medicine has also been raised in the present study.
作者 刘哲然
出处 《医学与哲学(B)》 2017年第10期81-84,共4页 Medicine & Philosophy(B)
关键词 经验医学 循证医学 精准医学 empirical medicine, evidence based medicine,precision medicine
  • 相关文献

参考文献7

二级参考文献55

  • 1王家良 刘鸣.循证医学[M].北京:人民卫生出版社,2001.177-188.
  • 2Echt DS,Leibson PR,Mitchel LB,et al.Cardiac arrhythmia suppression trial.N Engl Med,1989;321:406.
  • 3GISSI investigators.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
  • 4USUS-2 Collaborative group.Randomized trial of intravenous streptokinase,oral aspirin,both,or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2 Lancet,1988;Ⅱ:349.
  • 5The TIMI Ⅲ A investigators.Early effects of tissue-type plasminogen activator added to convention therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest.Results of the thrombolysis in myocardial ischemia(TIMI II A) trial. Circulation, 1993;87:38.
  • 6The TIMI ⅢB investigators.Effects of tissue plasminogen.activator and a comparison of early invasive and conservative strategies in umtable angina and non-Q wave myocardial infarction.Results of the TIMI ⅢB trial Circulation, 1994;89:1545.
  • 7The Scandinavian Simvastatin Survival Study Guoup.Randomized trial of cholesterol lowering in 4444 patients with coronary heart disesse:the Scandinavian Simvastatin Survival Study(4S).Lancet,1994;344:1383.
  • 8Sacks FM, Pfeffer MA, Moye LA,et al.The effect of pravastatin on coronary events after myocardial irfarction in patients with average cholesterol levels.N Engl J Med,1996;335:1001.
  • 9The LIPID Study group. Design features and baseline characteristics of the LIPID Study:a randomized trial in Patients with previous acute myocardial infarction and/or unstable angina pectoris.Am J Cardiol, 1995;76:474.
  • 10Amiodarone Trial Meta-Analysis Investigators.Effect of prophylactic amiodarone on motality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6500 patients in randomized trials.Lancet,1997;35):1417.

共引文献123

同被引文献122

引证文献16

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部